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ABSTRACT	
microRNAs	(miRNAs),	small	RNA	molecules	of	20–24	nts,	have	many	features	that	make	
them	 useful	 tools	 for	 gene	 expression	 regulation	—	 small	 size,	 flexible	 design,	 target	
predictability	and	action	at	a	late	stage	of	the	gene	expression	pipeline.	In	addition,	their	
role	in	fine-tuning	gene	expression	can	be	harnessed	to	increase	robustness	of	synthetic	
gene	 networks.	 In	 this	 work	 we	 apply	 a	 synthetic	 biology	 approach	 to	 characterize	
miRNA-mediated	 gene	 expression	 regulation	 in	 the	 unicellular	 green	 alga	
Chlamydomonas	 reinhardtii.	 This	 characterization	 is	 then	used	 to	build	 tools	based	on	
miRNAs,	such	as	synthetic	miRNAs,	miRNA-responsive	3’UTRs,	miRNA	decoys	and	self-
regulatory	loops.	These	tools	will	facilitate	the	engineering	of	gene	expression	for	new	
applications	and	improved	traits	in	this	alga.	
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Synthetic	biology	aims	 to	 facilitate	engineering	of	 living	 systems	using	molecular	 tools	
that	 control	 the	expression	of	 endogenous	and	 foreign	genes	 1.	 These	 tools	 are	often	
based	on	 the	engineering	of	 transcription	 factor	proteins	and	 their	binding	 sites.	RNA	
molecules	offer	an	alternative	to	protein-based	mechanisms	as	they	have	the	advantage	
of	 the	 relative	 ease	 in	 design,	modelling	 and	 construction	 2,3.	 Examples	 of	 RNA-based	
tools	 of	 gene	 expression	 are	 riboswitches,	 aptamers	 and	 components	 of	 the	 RNAi	
silencing	 pathway,	 which	 can	 be	 co-opted	 as	 sensors,	 information	 processors	 and	
regulator	devices	in	synthetic	gene	circuits	4.		
	 RNAi	 silencing	 is	 a	 highly	 conserved	 mechanism	 that	 regulates	 gene	
expression	and	defends	eukaryotic	genomes	from	viruses	and	transposons	5.	The	trigger	
of	 RNA	 silencing	 is	 a	 double-stranded	RNA	molecule	 that	 is	 processed	 into	 small	 RNA	
molecules	of	21-24	nts	by	a	RNase	III-type	nuclease	called	Dicer	6.	These	small	RNAs	are	
then	 associated	 with	 proteins	 of	 the	 Piwi/Argonaute	 family	 (AGO)	 to	 form	 the	 RNA-
induced	silencing	complex	 (RISC).	RISC	 is	guided	by	base	pairing	of	 the	small	RNA	to	a	
target	 RNA	 that	 is	 degraded	or	 translationally	 suppressed.	MicroRNAs	 (miRNAs)	 are	 a	
species	 of	 small	 RNAs	 that	 are	 derived	 from	 imperfect	 fold-back	 domains	 (miRNA	
precursors)	 of	 PolII	 RNA	 polymerase	 transcripts	 7.	 miRNAs	 play	 an	 important	 role	 in	
regulatory	 circuits	 by	 repressing	 transcription	 from	 leaky	 promoters,	 generating	
thresholds	 for	 gene	 activation	 and	 buffering	 gene	 expression	 fluctuations	 8.	 These	
features,	 in	 addition	 to	 their	 small	 size	 and	 easy	 targeting	 design	 based	 on	 sequence	
complementarity,	 make	 miRNAs	 useful	 tools	 in	 synthetic	 biology.	 Artificial	 miRNAs	
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(amiRNA)	have	been	widely	used	 for	 gene	 silencing	both	 in	animals	 and	plants	 9,10.	 In	
addition,	abundant	work	on	sequence	specificity,	mode	of	action	and	development	of	
miRNA	decoy	sequences	 8,11–13,	along	with	quantitative	 frameworks	 14,	have	 facilitated	
the	use	of	miRNAs	as	 regulatory	devices	of	 gene	expression	 in	 synthetic	 gene	 circuits	
15,16.		
	 Chlamydomonas	 reinhardtii	 (hereafter	 referred	as	 “Chlamydomonas”)	 is	one	of	
few	single-celled	organisms	that	possess	a	functional	microRNA	pathway	17,18.	This	green	
alga	belongs	to	a	lineage	that	diverged	from	that	of	higher	plants	approximately	1	billion	
years	ago.	 It	has	a	plant-like	chloroplast	but	animal-like	 flagellae	 19.	A	 fully	 sequenced	
genome	20,	extensive	transcriptomic	data,	a	large	collection	of	mutants	21,	tools	for	gene	
expression	 manipulation	 22	 and	 gene	 editing	 23–25	 make	 Chlamydomonas	 a	 powerful	
model	 organism	 for	 algal	 biology	 and	 biotechnology.	 The	 Chlamydomonas	 miRNA	
pathway	has	both	plant-like	and	animal-like	features,	such	as	3'	O-methylation,	as	with	
plant	 miRNAs,	 and	 overlap	 with	 protein	 coding	 genes	 as	 in	 animals	 17,18,26.	 AmiRNAs	
have	 been	 developed	 in	Chlamydomonas	 to	 knock	 down	 endogenous	 sequences	 27,28,	
and	 they	 have	 been	 used	 in	 reverse	 genetics	 experiments	 and	 in	 biotechnological	
applications	29–31.	However,	the	use	of	amiRNAs	in	synthetic	gene	circuits	requires	most	
extensive	analysis	of	their	inhibitory	properties	and	additional	tools.		
	 In	this	work	we	have	expanded	the	toolkit	 for	gene	expression	manipulation	 in	
Chlamydomonas	 by	 creating	 a	 set	 of	 synthetic	 miRNAs,	 miRNA-responsive	 3’UTRs,	
miRNA	target	mimics	and	miRNA-dependent	self-regulatory	loops.	In	addition,	we	have	
also	 established	 the	 methodology	 for	 the	 quantitative	 characterization	 of	 miRNA-
repression	 and	modulation	 of	 the	 response	 to	miRNA	 action.	 These	miRNA	 tools	 will	
facilitate	the	engineering	of	gene	expression	for	new	applications	and	improved	traits.		
	
RESULTS	
	
Design	of	a	miRNA-mediated	synthetic	gene	circuit	in	Chlamydomonas	
We	designed	a	simple	synthetic	circuit	to	characterize	the	repressive	activity	of	
miRNAs	 in	 Chlamydomonas	 (Figure	 1A).	 The	 circuit	 has	 a	 module	 in	 which	 the	
expression	of	a	fluorescent	protein	is	linked	to	the	production	of	a	miRNA	and	a	second	
module	 in	which	the	mRNA	of	a	second	fluorescent	protein	has	the	target	site	 for	the	
miRNA	of	module	1.	 The	 first	module	monitors	miRNA	abundance	 in	 vivo	 and	 second	
informs	about	the	level	of	miRNA	repression.		
To	facilitate	the	construction	of	these	modules	we	used	Golden	Gate	cloning	32.	
Gene	 expression	 regulatory	 sequences,	 antibiotic	 resistance	 genes,	 fluorescent	
reporters	and	miRNA	precursor	sequences	were	codon-optimized	for	Chlamydomonas	33	
and	"domesticated"	for	Golden	Gate	cloning	using	proposed	common	syntax	34.	Many	of	
these	DNA	parts	have	been	added	to	the	Chlamydomonas	MoClo	kit	35.	We	describe	in	
the	 following	 sections	 the	 construction	 of	 this	 gene	 circuit	 and	 characterization	 of	
synthetic	miRNAs.			
	
A	 fluorescent	 protein	 reporter	 can	 be	 engineered	 as	 proxy	 of	miRNA	 abundance	 in	
vivo	(Module	1)	
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The	 accumulation	 of	 a	 miRNA	 can	 be	 monitored	 by	 introducing	 the	 miRNA	
precursor	 sequence	 inside	 a	 fluorescent	 reporter	 gene,	 so	 that	miRNA	and	mRNA	are	
synthesized	 from	the	same	RNA	molecule	 36–38.	This	 configuration	 requires	 the	miRNA	
precursor	 sequence	 to	be	 in	 an	 intron	or	 in	 the	UTRs	of	 the	 fluorescent	protein	 gene	
(Figure	1B).	Most	endogenous	miRNA	precursors	in	Chlamydomonas	are	in	fact	similarly	
located	 within	 introns	 or	 3'UTRs	 of	 protein	 coding	 sequences	 (26,39;	 Supplementary	
Figure	1A).	We	therefore	created	a	series	of	DNA	constructs	where	a	miRNA	precursor	
was	inserted	within	the	UTRs	and	intron	of	a	fluorescent	protein	gene	and	analyzed	the	
levels	of	both	the	miRNA	and	fluorescence.	A	similar	approach	was	proposed	in	the	past	
to	 facilitate	 the	 screen	 of	 amiRNA-expressing	 clones	 in	 Chlamydomonas40.	 In	 this	
previous	approach,	an	amiRNA	was	cloned	between	the	 luciferase	gene	and	the	PSAD	
3’UTR,	 and	 some	 correlation	 between	 luciferase	 activity	 and	 amiRNA-dependent	
repression	effect	could	be	observed.	
We	 created	 an	 amiRNA	 using	 part	 of	 the	 precursor	 sequence	 of	 endogenous	
miR1157,	which	has	been	used	before	to	create	amiRNAs	27,40	(Suppl.	Figure	1B),	except	
that	 its	 sequence	 was	 modified	 to	 make	 it	 compatible	 with	 Golden	 Gate	 cloning	
(Supplementary	Figure	1C).	The	miR1157	precursor	was	suitable	for	this	project	because	
it	 is	 a	 short	 sequence	 (137	 bp)	 within	 the	 intron	 of	 the	 Cre12.g537671	 gene	 that	
specifies	 a	 single	miRNA.	 To	 confirm	 the	 production	 of	 a	 functional	miRNA	 from	 this	
construct	we	first	targeted	the	MAA7	gene.	MAA7	is	involved	in	tryptophan	metabolism	
41	 and	 amiRNA-mediated	 repression	 of	 the	 gene	 confers	 resistance	 to	 the	 metabolic	
drug	5-fluoroindole	(5-FI)	26.	
We	selected	three	sites	within	an	mVenus	reporter	gene	to	introduce	the	miRNA	
precursor	sequence:	 two	sites	 inside	an	 intron	 in	 the	coding	sequence	and	one	site	 in	
the	3’UTR	(Supplementary	Figure	1F).	The	intron	sequence	was	derived	from	the	second	
intron	of	 the	RBCS2	 that	had	been	scanned	using	ERISdb	 42	 to	ensure	 that	 the	miRNA	
precursor	did	not	disrupt	motifs	required	for	splicing.	We	avoided	inserting	the	miRNA	
precursor	into	the	5’UTR	because	we	observed	that	alteration	of	this	short	sequence	(46	
nts)	dramatically	reduced	the	expression	of	the	transgene	(see	below).	
	 Chlamydomonas	 wild	 type	 strains	 strongly	 silence	 transgenes,	 posing	 a	 major	
obstacle	to	obtain	high	and	stable	expression	of	our	reporter	genes	43,44.	To	overcome	
this	challenge,	we	used	the	UVM11	strain	for	all	of	the	subsequent	experiments	45.	This	
mutant	strain	supports	high	and	robust	transgene	expression	which	is	not	silenced	over	
time	 46.	 However,	 it	 is	 not	 known	 whether	 the	 mutation(s)	 responsible	 for	 the	 high	
transgene	 expression	 affects	 the	 miRNA	 pathway.	 We	 investigated	 this	 point	 by	
analyzing	 cleavage	 products	 of	 endogenous	 miRNAs	 (Supplementary	 Figure	 2A)	 and	
testing	 the	 functionality	of	 an	amiRNA	against	 the	MAA7	 gene	 (Supplementary	 Figure	
2B).	 Our	 results	 showed	 that	 the	miRNA	 pathway	 is	 functional	 in	 the	 UVM11	 strain.	
Therefore,	we	used	this	strain	for	the	construction	of	miRNA-based	gene	circuits.		
	 The	 control	 module	 1	 construct	 had	 mVenus	 genes	 without	 a	 miRNA	
(mVenus_PSAD	or	mVenus_RBCS	depending	on	 the	3’UTR)	 fused	 to	 the	paromomycin	
resistance	 cassette.	 The	 transformants	 (mVenus_PSAD,	 mVenus_RBCS)	 expressed	
different	 levels	 of	 mVenus	 due	 to	 the	 random	 integration	 of	 the	 construct	 and	
chromatin	 context-dependent	expression	 (Figure	1C;	 Supplementary	Figure	2C).	 These	
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levels	 of	 mVenus	 fluorescence	 were	 much	 higher	 than	 the	 autofluorescence	 of	 the	
UVM11	 strain	 (Figure	 1C,	 “backgr.”)	 or	 of	 clones	 transformed	only	with	 the	 antibiotic	
resistance	cassette	(Figure	1C,	“neg.control”;	Supplementary	Figure	2C).		
The	miRNA	precursor	 sequence	 in	 either	 of	 the	 intronic	 sites	 did	 not	 interfere	
significantly	with	the	expression	of	the	mVenus	gene	(“mVenus_PSAD	+miR	intron	site	1	
and	2”,	 Figure	1C).	 In	 contrast,	 the	 introduction	of	 the	miRNA	precursor	 in	 the	3’UTR	
(mVenus_RBCS	+miR	ter.	site	3)	prevented	mVenus	expression,	most	probably	due	the	
truncation	 of	 the	 mRNA	 by	 the	 action	 of	 Dicer.	 We	 therefore	 selected	 the	 reporter	
system	 with	 intronic	 miRNA	 precursor	 in	 site	 2	 to	 test	 the	 relationship	 of	 miRNA	
abundance	and	fluorescence.		
Northern	 blot	 of	 the	 amiRNA	 in	 different	 clones	 revealed	 a	 linear	 correlation	
between	 the	mVenus	 fluorescence	 and	miRNA	 abundance	 (Figure	 1D,	 1E)	 at	 low	 and	
intermediate	 levels	 (Figure	 1E).	 The	 miRNA	 produced	 from	 our	 reporter	 system	 was	
functional,	 as	 evidenced	 by	 the	 fact	 that	 clones	with	 high	mVenus	 fluorescence	were	
resistant	to	5-FI,	indicating	repression	of	the	MAA7	gene	(Figure	1F).	In	contrast,	clones	
transformed	with	 the	 control	 construct	 (the	mVenus	 gene	 lacking	 the	 intronic	miRNA	
precursor)	were	unable	to	grow	on	media	containing	5-FI.	In	conclusion,	the	engineering	
of	an	intronic	miRNA	precursor	inside	the	mVenus	gene	allows	the	use	of	fluorescence	
as	a	proxy	for	the	amount	of	miRNA	inside	the	cell.		
	
Construction	 of	 a	 reporter	 system	 to	 measure	 miRNA-mediated	 gene	 repression	
activity	of	a	miRNA	(Module	2)	
For	the	construction	of	module	2	of	the	miRNA-mediated	synthetic	gene	circuit,	
we	used	a	second	fluorescent	protein,	mCherry,	as	part	of	a	two-color	reporter	system	
to	measure	 the	 repressive	 activity	 of	 a	miRNA.	 The	 emission	 spectra	 of	mCherry	 and	
mVenus	are	non-overlapping,	allowing	simultaneous	quantification	of	both	fluorescent	
signals	in	vivo.		
	 To	 optimize	 the	 amiRNA	 targeting	 we	 introduced	 the	 21-nt	 amiRNA	 target	
sequence	 at	 three	different	 locations:	 in	 the	 5'UTR	 right	 upstream	of	 the	 Start	 codon	
(site	 A),	 4-nt	 downstream	 the	 Stop	 codon	 (site	 B),	 and	 119-nts	 upstream	 of	 the	
polyadenylation	 site	 (site	 C)	 (Figure	 2A).	 Clones	 expressed	 high	 levels	 of	 mCherry	
fluorescence	when	 the	 21-nt	miRNA	 target	 site	was	 introduced	 into	 both	 sites	 of	 the	
3’UTR	and	 low	levels	when	it	was	 in	the	5’UTR	(Supplementary	Figure	3),	 likely	due	to	
disruption	of	motifs	important	for	protein	translation.		
We	 then	 transformed	 a	 single	 line	 with	 high	 levels	 of	 mCherry	 with	 mVenus	
constructs	fused	to	a	paromomycin	resistance	cassette.	Double	transgenic	lines	with	the	
paromomycin	 resistance	 had	 varying	 levels	 of	 mVenus	 and	 mCherry	 (Figure	 2B)	
depending	on	the	amiRNA	target	site	and	whether	mVenus	included	the	intronic	miRNA	
(Figure	 2B,	 “mVenus	 (+intr.	 miRNA)”	 vs	 “mVenus”).	 The	 mCherry	 fluorescence	 was	
reduced	 by	 the	 amiRNA	 when	 the	 miRNA	 recognition	 site	 was	 in	 the	 5’UTR	 (site	 A,	
Figure	2B)	or	 close	 to	 the	polyadenylation	site	 in	 the	3’UTR	 (site	C,	Figure	2B).	 	There	
was	no	reduction	when	the	target	site	was	introduced	close	to	the	stop	codon	(site	B)	
(Figure	 2B).	 We	 chose	 site	 C	 for	 our	 further	 analysis	 because	 there	 was	 significant	
amiRNA	repression	against	a	background	of	high	level	of	mCherry	fluorescence.	
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Generation	of	synthetic	miRNAs	and	target	3’UTRs	
	 We	next	proceeded	to	design	“synthetic	miRNAs”	(artificial	miRNAs	with	target	
sequences	not	present	in	the	Chlamydomonas	genome)	for	incorporation	into	this	two	
module	 system	 using	 the	 MicroRNA	 Designer	 tool	 of	 the	 WMD3	 website	 47.	 The	
algorithm	was	fed	with	a	scrambled	sequence	of	a	randomly	selected	Chlamydomonas	
gene	as	 target	 sequence	and	 the	miRNA	 sequences	 generated	were	 filtered	based	on	
the	 following	 criteria:	 predicted	 high	 efficiency	 and	 specificity,	 GC	 content	within	 the	
range	of	endogenous	miRNAs,	absence	of	ATG/CAT	triplets,	and	absence	of	the	BpiI/BsaI	
recognition	 sites	 that	 are	 used	 for	 the	 Golden	 Gate	 cloning.	 In	 addition	 the	 miRNA	
sequences	had	to	have	a	uridine	residue	at	the	first	position	of	the	5’	end,	a	feature	that	
is	observed	in	most	endogenous	miRNAs	in	Chlamydomonas	17,18	and	there	should	be	no	
potential	 “off	 targets”	 with	 full	 sequence	 complementarity	 in	 the	 Chlamydomonas	
genome.	We	selected	seven	of	these	sequences	to	test	their	repressive	activity	(Figure	
3).		
	 We	 introduced	 21-nt	 sequence	 with	 perfect	 complementarity	 to	 each	 of	 the	
seven	synthetic	miRNAs	into	site	C	(Figure	2)	of	the	mCherry	reporter	gene	and	then	re-
transformed	 strains	 with	 high	 levels	 of	 mCherry	 fluorescence	 with	 mVenus	 cassettes	
with	synthetic	miRNAs	at	intronic	site	2	(Figure	3A,	3B).	The	mVenus	cassette	lacking	the	
miRNA	precursor	was	the	control.	All	seven	synthetic	miRNAs	repressed	the	mCherry	by	
varying	levels	between	66	and	93%	(Figure	3C).	Our	two-module	system	is,	therefore,	a	
functional	framework	for	characterization	of	synthetic	miRNAs	in	Chlamydomonas.		
	
Characterization	of	the	repressive	activity	of	a	synthetic	miRNA	
	 We	 selected	 the	 synthetic	 miRNA	 miR1	 as	 an	 example	 to	 characterize	 the	
repressive	 activity	 of	 synthetic	 miRNAs.	 Clones	 displaying	 varying	 levels	 of	 mVenus	
showed	 a	 high	 degree	 of	 anti-correlation	with	mCherry,	 only	when	 the	mVenus	 gene	
had	 the	 intronic	 miRNA	 (Figure	 4A).	 mCherry	 fluorescence	 plateaued	 at	 low-
intermediate	 level	 of	 mVenus	 (Figure	 4B),	 indicating	 that	 the	 mCherry	 mRNA	 was	
hypersensitive	to	miR1	levels.		
	 We	 also	 characterized	 miR1-dependent	 repression	 at	 molecular	 level	 by	
Northern	blotting	(Figure	4C).	The	mVenus	fluorescence,	mVenus	mRNA	and	miR1	levels	
correlated	well	(Figure	4A)	and,	as	expected,	the	levels	of	the	mCherry	mRNA	reduced	
as	the	levels	of	mVenus	mRNA	and	miR1	increased.	The	decrease	in	mCherry	mRNA	was	
associated	with	the	appearance	of	two	bands	that,	based	on	their	size,	could	correspond	
to	full	length	and	miR1-dependent	cleaved	transcripts.		
Consistent	with	 this	 interpretation	we	detected	an	RT-PCR	product	 from	3’UTR	
of	the	mCherry	gene	by	5’RACE	(Figure	4D)	in	clones	expressing	the	mVenus	gene	with	
the	intronic	miR1	precursor	(Figure	4D,	“+intronic	miRNA”)	but	not	from	clones	with	the	
mVenus	gene	lacking	the	miRNA	(Figure	4D,	“mVenus”).	The	5’	end	of	the	RT-PCR	was	
complementary	to	positions	10	and	11	of	miR1	(Figure	4E),	confirming	the	specificity	of	
the	miRNA-dependent	cleavage	of	mCherry	mRNA	and	that	mCherry	silencing	by	miR1	
occurs	by	RNA	degradation	instead	of	translational	repression.		
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	 We	 extended	 our	 characterization	 to	 single	 cell	 level	 by	 using	 fluorescence	
microscopy.	Cultures	of	 double	 transgenic	 lines	 expressing	mCherry	 and	mVenus	with	
intronic	miR1	 precursor	 (Figure	 4F	 top	 panels),	 or	without	miRNA	 (Figure	 4F,	 bottom	
panels)	were	mixed	with	cells	expressing	only	the	mCherry	reporter	in	order	to	compare	
mCherry	 fluorescent	 levels.	 As	 expected,	 cells	 displaying	mVenus	 fluorescence	 in	 the	
transgenic	 line	 that	 expressed	 miR1	 had	 reduced	 levels	 of	 mCherry	 fluorescence.	 In	
contrast,	mCherry	 fluorescence	was	not	 reduced	 in	mVenus	positive	cells	 that	did	not	
harbor	intronic	miR1	(bottom	panel).	In	conclusion,	our	characterization	shows	specific	
and	efficient	silencing	by	synthetic	miRNAs	at	population	and	single	cell	level.			
	
Modulation	of	the	miRNA	repressive	activity		
The	 silencing	 activity	 of	 a	 miRNA	 relies	 on	 sequence	 complementarity	 to	 its	
target	8,11	and	alteration	of	this	complementarity	can	be	used	as	a	way	to	modulate	the	
response	of	a	target	mRNA.	Yamasaki	et	al.	previously	showed	that	complementarity	to	
a	Chlamydomonas	miRNA	seed	region	was	sufficient	to	induce	moderate	repression	48.	
We	 further	 analyzed	 the	 effects	 of	 sequence	 complementarity	 with	 our	 two-module	
system.	In	order	to	change	the	repression	activity	of	the	synthetic	miRNAs,	we	mutated	
the	two	nucleotides	that	flank	the	miR1-RISC	cleavage	site	on	mCherry	transcript	(sites	
opposite	to	positions	10’	and	11’	of	miR1)	(Figure	5A)	and	transformed	with	an	mVenus	
construct	 carrying	 the	 intronic	miR1	precursor.	As	 control,	we	also	 transformed	a	 line	
expressing	mCherry	carrying	a	target	site	with	perfect	complementarity	to	miR1.	The	2-
nt	mismatch	on	miR1	target	site	reduced	silencing	of	mCherry	compared	to	the	control	
(Figure	5A):	the	control	mCherry	construct	was	silenced	at	high	mVenus	levels	down	to	
15%	of	the	initial	value	whereas,	with	the	mutant	target	and	similar	mVenus	levels,	the	
mCherry	 fluorescence	 reduced	 down	 to	 40%.	 In	 addition,	 there	 was	 a	 more	 gradual	
gradient	of	silencing	of	mCherry	with	the	mismatched	target	(Figure	5A).		
mCherry	 mRNA	 levels,	 determined	 by	 RT-qPCR,	 correlated	 with	 fluorescence	
(Figure	 5B)	 indicating	 that,	 even	 in	 the	 absence	 of	 perfect	 complementarity,	 miR1	
triggers	 silencing	 of	mCherry	 by	 RNA	 degradation.	 Consistent	with	 this	 interpretation	
the	miR1-dependent	cleavage	products	of	mCherry	mRNAs	were	present	for	both	types	
of	target	site,	although	at	lower	levels	with	2nt-mismatch	(Figure	5C-E).	
Altogether,	 these	 results	 show	 that	 the	 introduction	 of	mismatches	 at	miRNA	
target	site	modulates	the	miRNA-dependent	silencing	and	provides	a	method	to	obtain	
a	close	to	linear	relationship	between	the	miRNA	and	target	levels.		
		
A	miRNA	decoy	partially	inactivates	a	synthetic	miRNA	
As	well	as	modulating	the	activity	of	a	miRNA,	it	would	be	interesting	to	develop	
tools	 that	 inactivate	 miRNAs	 in	 Chlamydomonas	 such	 as	 miRNA	 decoys	 (for	 reviews	
49,50).	 These	 are	 RNA	 molecules	 carrying	 sequences	 with	 high	 complementarity	 to	 a	
miRNA	that	specifically	sequester	and/or	trigger	the	degradation	of	the	miRNA,	resulting	
in	the	de-repression	of	its	targets.		
To	assess	the	functionality	of	miRNA	decoys	in	Chlamydomonas,	we	designed	a	
miRNA	decoy	in	which	one	(RNA	decoy	1X)	or	two	(RNA	decoy	2X)	24-nt	sequences	with	
perfect	complementarity	to	miR1,	except	for	a	3-nt	bulge	at	the	RISC	cleavage	site	were	
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introduced	 into	 the	3’UTR	of	a	mVenus	gene	 (Figure	6A,	Supplementary	Figure	4A).	 It	
has	been	shown	before	that	miRNA	decoys	embedded	into	the	3’UTR	of	β-glucorinadase	
(GUS)	are	effective	at	inactivating	plant	miRNAs	51,52.	In	our	case,	the	3’UTR	was	derived	
from	 the	PSAD	 gene,	 and	 a	 48-nt	 linker	 sequence	 identical	 to	 the	one	used	 in	 53	was	
inserted	in	between	the	two	miR1	mimic	sites.	A	construct	without	mimic	sites	was	used	
as	control.		
The	miRNA	decoys	were	fused	to	a	zeocin	resistance	cassette	and	transformed	
into	one	of	the	double	transgenic	lines	described	in	the	previous	section	(Figure	6B)	in	
which	 mCherry	 was	 silenced	 by	 miR1	 from	 an	 mVenus	 gene.	 The	 miRNA	 target	 in	
mCherry	carried	a	miR1	target	site	with	a	2nt-mismatch	(Figure	5E).		
Transformants	 carrying	 either	 RNA	 decoy	 1X	 and	 2X	 had	 higher	 mCherry	
fluorescence	 than	 transformants	 with	 the	 control	 mVenus	 construct	 (Figure	 6C),	 and	
lower	mCherry	 fluorescence	 than	 transformants	 lacking	miR1.	 These	 results	 therefore	
suggest	that	our	miRNA	decoy	constructs	triggered	partial	de-repression	of	the	mCherry	
gene.	This	de-repression	of	mCherry	was	not	potentiated	by	the	presence	of	a	second	
mimic	site	in	the	miRNA	decoy.	The	derepression	effect	of	the	miRNA	decoy	was	less	in	
cells	 in	 which	 the	 miRNA	 target	 site	 was	 perfectly	 complementary	 to	 miR1		
(Supplementary	Figure	4B).			
From	 these	 results	 we	 conclude	 that	 miRNA	 inactivation	 by	 miRNA	 decoys	 is	
possible	 in	Chlamydomonas	 and	 can	be	 incorporated	 into	 the	design	of	miRNA-based	
synthetic	 gene	 circuits.	 However,	 efficient	 miRNA	 inactivation	 will	 require	 additional	
optimization	of	the	miRNA	decoy	design	and	expression,	and	it	will	be	influenced	by	the	
degree	 of	 sequence	 complementarity	 between	 the	 miRNA	 and	 its	 target	 RNA	
(Supplementary	Figure	4B).	
	
Construction	of	self-regulatory	loops	using	intronic	miRNAs.		
miRNAs	 can	 be	 engineered	 into	 feed-forward	 loops,	 which	 may	 buffer	 gene	
expression	 noise	 and	 adaptation	 to	 stimuli	 54,55.	 To	 explore	 this	 possibility	 in	
Chlamydomonas	 we	 used	 the	 elements	 characterized	 above	 to	 construct	 an	 intronic	
miRNA	 self-regulatory	 loop	 (iMSL),	 consisting	 of	 an	 intronic	 miRNA	 that	 silences	 the	
mRNAs	derived	 from	 the	 same	molecule	as	 the	miRNA	 (Figure	7A).	This	 simple	 circuit	
has	 the	 potential	 of	 extending	 auto-regulatory	 properties	 to	 genes	 which	 are	 not	
transcriptional	factors.		
	 To	create	an	iMSL,	we	fused	the	coding	sequence	of	the	mVenus	gene,	harboring	
an	 intronic	 miRNA	 precursor,	 with	 the	 PSAD-derived	 3’UTRs	 described	 earlier.	 These	
3’UTRs	carried	a	target	site	for	the	intronic	miRNA.	We	tested	two	different	3’UTRs,	one	
carrying	 a	 target	 site	with	 high	 complementarity	 to	 the	 intronic	miRNA	 (construct	 3),	
and	a	second	with	two	extra	mismatches	to	the	miRNA	at	positions	8’	and	9’	(construct	
4)	 (Figure	7B).	These	mismatches	reduced	the	silencing	effect	of	 the	miRNA	when	this	
was	expressed	from	a	different	gene	(Supplementary	Figure	5A),	similarly	to	what	was	
described	 in	a	previous	 section.	A	 construct	 lacking	 the	 intronic	miRNA	precursor	and	
target	sequence	(construct	1),	and	another	construct	with	the	intronic	miRNA	precursor	
but	without	the	target	sequence	(construct	2),	were	used	as	controls.	In	each	instance,	
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the	mVenus	gene	was	fused	to	the	paromomycin	resistant	cassette	for	the	isolation	of	
transformants.		
mVenus	fluorescence	of	individual	clones	from	each	transformation	is	shown	in	
the	 boxplot	 in	 Figure	 7C.	 Transformation	 with	 control	 constructs	 1	 and	 2	 produced	
transformants	with	a	broad	range	of	fluorescence	intensities	whereas,	with	construct	3,	
where	an	iMSL	was	implemented,	the	transformants	had	very	low	levels	of	fluorescence	
due	 to	 self-silencing.	 The	 presence	 of	 mismatches	 into	 the	 miRNA	 target	 sequence	
(construct	 4)	 partially	 recovered	 the	 mVenus	 fluorescence	 levels,	 most	 likely	 due	 to	
reduced	self-silencing.	These	results	confirm	that	miRNA-mediated	iMSL	are	functional	
in	Chlamydomonas	and	can	be	engineered.	
Mathematical	 modeling	 predicts	 that	 gene	 expression	 variability	 would	 be	
buffered	by	an	iMSL	in	which	the	miRNA	has	low/intermediate	repressive	activity	56.	To	
test	this	possibility,	we	analyzed	cell-to-cell	variability	in	mVenus	fluorescence	in	clones	
carrying	 the	 constructs	 described	 in	 the	 previous	 section.	Quantification	 of	 single	 cell	
fluorescence	was	 performed	 using	 flow	 cytometry	 57.	 As	 an	 example	 of	 an	 iMSL	with	
intermediate	 repressive	 activity	 we	 used	 construct	 4.	 In	 addition,	 to	 distinguish	 the	
effect	of	 the	self-regulation	versus	miRNA	repression,	we	 included	a	control	 construct	
similar	to	construct	4	except	for	the	fact	that	the	miRNA	was	not	linked	to	the	mVenus	
mRNA	(Figure	7B).			
Figure	7D	shows	that	the	CV2,	as	a	measurement	of	variability,	changed	with	the	
average	 level	of	expression,	and	 it	 increased	as	expression	decreased.	Clones	 carrying	
the	 iMSL	 (construct	 4)	 had	 less	 variability	 than	 the	 controls	 (constructs	 1	 and	 2),	
especially	at	intermediate	and	low	levels	of	average	mVenus	expression.	However,	there	
was	 a	 similar	 reduction	 in	 cell-to-cell	 variability	 when	 the	 miRNA	 was	 produced	
independently	 of	 the	 mVenus	 mRNA	 (control	 construct).	 These	 results	 suggest	 that	
miRNA	repression	 is	enough	to	confer	certain	buffering	against	variability	but	that	the	
presence	of	an	iMSL	does	not	add	extra	buffering	capacity,	at	least	under	the	conditions	
assayed.		
	
DISCUSSION		
	
In	this	work	we	have	constructed	a	two-module	miRNA	system	with	applications	
in	synthetic	biology	in	Chlamydomonas.	The	most	obvious	application	is	in	the	design	of	
a	negative	switch	for	gene	silencing.	We	show	how	the	negative	miRNA	regulator	can	be	
most	 usefully	 integrated	 into	 an	 intron,	 and	 how	 the	 expression	 level	 of	 a	 reporter	
construct	encoded	in	the	adjacent	exons	can	be	used	to	indicate	the	relative	level	of	the	
miRNA	 (Figure	1).	 In	 the	present	work,	 this	design	was	under	a	 constitutive	promoter	
but,	in	principle,	a	similar	design	can	be	used	under	inducible	or	regulated	promoters.	
It	 is	 likely	 that	miRNAs	 in	 nature	 are	 fine	 tuners	 rather	 than	 two-state	 on/off	
regulators	 of	 gene	 expression	 52,58.	 Such	 fine-tuning	would	 also	 be	 useful	 in	 synthetic	
biology.	We	were	 able	 to	 confirm	 this	 role	 of	miRNAs	 in	 Chlamydomonas	 by	 varying	
miRNA	 levels	 and	 by	modifying	 the	 complementarity	 between	 the	miRNA	 and	 target	
sequences	 (Figures	4	and	5).	 It	 is	 likely,	however,	 that	 robust	and	 stable	 intermediate	
levels	 of	 gene	 silencing	 are	 more	 easily	 achieved	 by	 changing	 sequence	
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complementarity	rather	than	through	modulation	of	the	miRNA	abundance.	We	showed	
that	 perfect	 complementarity	 between	 the	 target	 site	 and	 the	miRNA	 showed	 a	 non-
linear	relationship	between	the	miRNA	levels	and	the	degree	of	target	silencing	(Figure	
4	and	5).	With	the	mismatched	target-miRNA	(Figure	5),	however,	this	relationship	was	
more	 linear,	 facilitating	 the	 isolation	 of	 intermediate	 levels	 of	 expression.	 A	 similar	
effect	 has	 been	 described	 for	 an	 animal	 miRNA	 when	 affinity	 for	 its	 target	 was	
reduced14.	It	is	likely	that	this	result	could	be	extended	to	other	miRNA	sequences.		
A	 third	potential	 application	of	miRNAs	 is	 to	 reduce	noise	 in	 the	expression	of	
synthetic	 gene	modules	 59.	Our	original	 idea,	 supported	by	mathematical	modeling	 56,	
was	that	a	single	component	system	with	self-regulatory	capacity	by	implementation	of	
a	cis-acting	miRNA	would	achieve	noise	reduction	(Figure	7).	Although	this	was	the	case,	
there	 was,	 however,	 a	 similar	 noise	 reduction	 by	 action	 of	 a	 trans-acting	 miRNA,	
suggesting	 the	 existence	 of	 feedback	 between	 miRNA-mediated	 regulation	 and	 the	
other	mechanisms	affecting	RNA	accumulation.	Schmiedel	et	al.	showed	that	reduction	
of	the	intrinsic	noise	of	protein	expression	is	a	generic	property	of	animal	miRNAs	60.	It	is	
possible	 that	 the	noise	buffering	effect	 that	we	have	measured	could	be	attributed	to	
this	generic	property.		
We	 have	 pointed	 out	 elsewhere	 that	 the	miRNA	 system	of	Chlamydomonas	 is	
atypical	 of	 both	 land	 plants	 and	 animals	 26,39.	 Our	 finding	 that	 mismatched	 miRNAs	
mediate	 target	RNA	cleavage	 (Figure	5D	and	E)	provides	 further	 support	 for	 this	 idea.	
The	atypical	nature	of	the	Chlamydomonas	miRNA	system	is	also	reflected	in	the	finding	
that	miRNA	decoys	are	only	partially	effective	at	blocking	the	action	of	a	miRNA.		
Several	 possibilities	 can	 account	 for	 the	 lack	 of	 efficiency	 of	miRNA	 decoys	 in	
Chlamydomonas.	 One	 possibility	 is	 that	 the	 machinery	 responsible	 for	 miRNA	
degradation	 upon	 binding	 the	 decoy	molecule	 is	 missing	 in	 Chlamydomonas.	 Little	 is	
known	 about	 the	 algal	 miRNA	 degradation	 pathway,	 and	 no	 functional	 homologs	 of	
SND1	 and	 SND2,	 which	 are	 involved	 in	 decoy-triggered	 miRNA	 degradation	 in	
Arabidopsis	53,	have	been	identified.		
Another	possibility	is	that	a	higher	accumulation	of	the	miRNA	decoy	relative	to	
the	miRNA	is	required	to	obtain	effective	degradation	of	the	target	miRNA.	We	tried	to	
maximize	 expression	 of	 the	miRNA	 decoy	 by	 expressing	 the	 construct	 under	 a	 strong	
promoter	(PSAD)	and	by	linking	it	to	the	zeocine	selection	marker,	previously	shown	to	
promote	high	levels	of	expression	of	recombinant	sequences	61.	However,	as	our	miRNA	
decoy	was	part	of	 a	mRNA	molecule,	 its	degradation	might	be	 faster	 than	 the	miRNA	
itself	and	prevent	accumulation.		
Finally,	 it	 is	 also	 possible	 that	 the	 miRNA	 and	 our	 miRNA	 decoy	 construct	
accumulate	 in	 different	 subcellular	 compartments	 in	 Chlamydomonas.	 As	 our	 miRNA	
decoy	molecule	is	a	mRNA,	we	expect	that	it	most	likely	accumulates	in	the	cytoplasm	
associated	with	ribosomes.	If,	on	the	other	hand,	the	RISC	complex	is	predominantly	in	
other	cytoplasmic	sub-compartments	or	in	the	nucleus,	this	might	prevent	the	action	of	
the	decoy.	Being	 the	case,	 incorporating	decoy	sequences	onto	molecules	 that	do	not	
associate	 with	 polysomes,	 such	 as	 nuclear	 RNAs	 or	 long	 non-coding	 RNAs	 (Franco-
Zorrilla	 et	 al.,	 2007)	 could	 result	 in	higher	 efficiency	of	 the	decoy.	Alternative	designs	
incorporating	the	decoy	sequences	 into	RNA	molecules	more	resistant	to	degradation,	
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such	 as	 circular	 RNAs	 and	 TuD	 hairpins	 62,	 could	 be	 implemented	 to	 increase	 the	
accumulation	of	the	miRNA	decoy	molecule.		
The	 tools	and	methodology	described	 in	 this	work	will	be	useful	 to	 investigate	
these	possibilities	and	to	guide	future	efforts	for	the	engineering	of	gene	expression	in	
this	alga	although	it	is	clear	that	each	miRNA	circuit	will	need	to	be	optimized	and	tested	
for	off-target	effects.		
There	 is	 abundant	 work	 on	 miRNA-based	 regulation	 in	 animal	 cells,	 using	
reporter	 systems	 similar	 to	 the	ones	described	 in	our	work.	Animal	miRNAs	have	also	
been	 used	 to	 engineer	 synthetic	 circuits	 with	 complex	 behaviors.	 This	 level	 of	
characterization	and	application	is	missing	in	plants,	and	the	present	work	can	be	used	
as	a	proof-of-principle	for	further	miRNA-based	manipulation	of	gene	expression	in	the	
alga	and	higher	plants.	Our	work	establishes	the	basic	tools	and	design	for	this	aim.	In	
addition,	some	of	the	findings	of	the	current	work	may	prompt	further	investigation	in	
animal	 systems,	 or	 inspire	 new	 circuit	 designs	 to,	 for	 example,	 reduce	 cell-to-cell	
variability	of	a	gene	under	the	repression	of	a	miRNA,	independently	of	the	presence	of	
a	self-mediated	loops.	,	and	another	is	the	use	of	synthetic	miRNAs,	which	avoid	using	
endogenous	miRNAs.		
	
	
	
	
METHODS	
Strains,	growth	conditions	and	transformation	
The	Chlamydomonas	cell-wall	deficient	strain	UVM11	strain,	kindly	provided	by	Dr	Ralph	
Bock	 (Max	Planck	 Institute	 of	Molecular	 Plant	 Physiology,	Germany),	was	 used	 in	 this	
work	(Supplementary	Table	S1).	This	strain	was	originally	isolated	in	a	screen	for	mutant	
strains	which	expressed	high	levels	of	a	transgene	45.	In	some	experiments	the	strain	CC-
1883,	 obtained	 from	 the	 Chlamydomonas	 Resource	 Centre	 was	 used	 (Supplementary	
Table	 S1).	 Liquid	 or	 solid	 2-amino-2-(hydroxymethyl)-	 1,3-propanediol	 (TRIS)-acetate-
phosphate	(TAP)	media	was	used	as	growing	media	63,	and	cultures	were	 incubated	at	
25°C	under	 continuous	 illumination	 (125	µE	m-1	 s-1).	 To	 test	 suppression	of	 the	MAA7	
gene,	TAP	media	was	 supplemented	with	10	µM	of	 the	metabolic	drug	5-fluoroindole	
(5-Fl,	 Merck),	 from	 a	 stock	 solution	 of	 1	 mM	 prepared	 in	 DMSO.	 For	 selection	 of	
transformants,	TAP	media	was	supplemented	with	15	µg/ml	paromomycin,	hygromycin	
or	zeocin.			
	 For	 transformation,	 50	 ml	 cultures	 were	 grown	 up	 to	 approximately	 5x106	
cells/ml,	spun	down	and	resuspended	in	0.9	ml	TAP.	Cells	were	mixed	with	200-500	ng	
of	 a	 linear	 DNA	 fragment	 that	 carries	 the	 indicated	 DNA	 cassette	 excised	 from	 the	
plasmid	backbone	and	further	purified	from	an	agarose	gel.	The	mix	was	split	into	three	
tubes	 containing	0.3	ml	of	400-600	nm	diameter	glass	beads,	 and	 shaken	on	a	vortex	
mixer	at	max	speed	for	15	sec.	The	cell	suspension	was	then	transferred	onto	solid	TAP	
containing	the	appropriate	antibiotic.	Plates	were	incubated	in	dark	for	2	days,	and	then	
under	 continuous	 light	 until	 the	 appearance	 of	 colonies.	 Colonies	 were	 picked	 and	
streaked	out	onto	fresh	TAP	plates	containing	antibiotics.		
	 11	
	
Plasmid	construction	
Plasmids	used	in	this	work	were	constructed	using	a	modular	strategy	based	on	Golden	
Gate	cloning	and	following	the	syntax	proposed	previously	34.		Backbones	described	in	64	
were	 used,	 and	 Chlamydomonas	 specific	 level	 zero	 DNA	 parts	 were	 created	 by	 site-
directed	mutagenesis	 or	 gene	 synthesis.	 Conditions	 for	 the	 one-pot	 digestion-ligation	
reaction	were	37°C	for	20	sec,	26	cycles	of	37°C	for	3	min-16°C	for	4	min,	and	finally	5	
min	 at	 50°C	 and	 5	min	 at	 80°C.	Many	 of	 the	DNA	 parts	 used	 in	 this	work	 have	 been	
added	to	the	Chlamy	MoClo	kit	35	or	have	counterparts	in	the	kit.		
	 miRNA	precursors	encoded	inside	the	intron	sequence	of	the	mVenus	gene	were	
constructed	by	Golden	Gate	(Supplementary	Figure	6).	The	miRNA	precursor	sequence	
was	assembled	using	 five	short	dsDNA	molecules	of	48	 to	74	bp,	each	 formed	by	 two	
annealed	 complementary	 oligonucleotides.	 Each	 of	 the	 dsDNA	 fragments	 carried	BpiI	
sites	 on	 both	 ends	 that	 generated	 different	 overhangs	 upon	 digestion,	 allowing	
assembly	and	directional	cloning	into	recipient	plasmid	pFJN61.		The	one-pot	digestion-
ligation	reaction	consisted	in	0.045	pmol	of	plasmid	pFJN61,	0.175	pmol	of	each	dsDNA	
fragment,	1X	NEB	T4	DNA	ligase	buffer,	0.1	mg/ml	of	BSA,	5U	of	BpiI	(Thermo)	and	200U	
of	 NEB	 T4	 DNA	 ligase,	 in	 a	 15	 μl	 volume	 reaction.	 The	 reaction	 was	 incubated	 as	
described	 above.	 dsDNA	 fragments	 were	 annealed	 by	 incubating	 500	 pmol	 of	 each	
oligonucleotide	in	10	mM	Tris-HCl	pH	8.0,	1	mM	EDTA,	0.1	M	NaCl,	at		95°C	for	4	min,	
and	then	let	to	cool	down	to	room	temperature	for	10	min.	Once	the	miRNA	precursor	
sequence	was	incorporated	into	the	intron,	the	assembly	of	the	remaining	mVenus	gene	
was	performed	as	described	in	35	by	Golden	Gate	cloning.	The	level	2	acceptor	plasmid	
of	 choice	was	pFPC2,	derived	 from	pAGM4723	 65.	 The	pFPC2	plasmid	 lacks	 sequences	
for	Agrobacterium	 T-DNA	 integration,	 and	 has	 symmetrical	BsaI	 sites	 to	 separate	 the	
multigene	 cassette	 from	 the	 backbone	 sequence.	 After	 BsaI	 digestion,	 the	multigene	
cassette	 was	 extracted	 from	 gel	 and	 used	 for	 transforming	 Chlamydomonas	 as	
described	above.		
	 To	incorporate	miRNA	target	sequences	into	the	PSAD	3’UTR,	we	employed	the	
NEB	 Q5®	 site-directed	 mutagenesis	 kit,	 using	 primers	 described	 in	 Supplementary	
Figure	 6D.	 The	 modified	 3’UTRs	 were	 sequenced	 and	 assembled	 into	 transcriptional	
units	and	multigene	cassettes	as	described	in	35.		
	
	
	
RNA	extraction	
RNA	 isolation	 was	 carried	 out	 as	 previously	 described	 17.	 A	 detailed	 protocol	 can	 be	
found	at	http://www.plantsci.cam.ac.uk/research/davidbaulcombe	
/methods/downloads/smallrna.pdf/view.	 We	 did	 the	 following	 modifications	 on	 the	
protocol:	RNA	was	extracted	from	live	cells	after	centrifuging	the	culture,	without	prior	
freezing;	PureZol	(Biorad)	was	used	instead	of	Trizol	and	volumes	were	scaled	down	to	
perform	 extraction	 in	 2	 ml	 tubes.	 RNA	 quality	 was	 assessed	 in	 gel	 and	 quantified	 in	
Nanodrop	(ThermoFisher	scientific).	RNA	was	stored	at	-80°C.	
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Northern	blots	and	qPCR	
Small	 RNA	 detection	 by	 Northern	 blot	 was	 performed	 as	 previously	 described	 in	 17	
(http://www.plantsci.cam.ac.uk/research/davidbaulcombe/	
methods/downloads/smallrna.pdf/view)	 (Supplementary	 Methods).	 Probe	 sequences	
are	indicated	in	Supplementary	Table	S2.	
	 cDNA	for	relative	quantification	of	gene	expression	by	qPCR	was	made	from	5	µg	
total	RNA	using	SuperScript	IV	Reverse	Transcriptase	(RT)	(ThermoScientific)	and	primed	
with	oligo	dTs.	5	µg	of	total	RNA	was	retro-transcribed	with	200	U	of	RT	at	55°C	for	1	h.	
RT	 was	 inactivated	 at	 80°C	 for	 10	 min.	 Contaminating	 DNA	 in	 the	 RNA	 sample	 was	
removed	with	2	U	of	TurboDNase	(ThermoScientific)	for	20	µg	of	total	RNA,	incubating	
at	37°C	for	30	min.	cDNA	was	diluted	1:20	and	4	µl	were	used	 in	a	25	µl	PCR	reaction	
containing	0.3	µM	of	each	primer,	2.5	U	of	Taq	polymerase	(PCRbio),	4%	(v/v)	DMSO,	5	
mM	dNTPs	and	1X	SYBR	Green	 (ThermoScientific).	A	 control	qPCR	 reaction	 from	each	
sample	treated	with	DNase	but	no	RT	was	carried	out	to	assess	potential	genomic	DNA	
contamination.	1:5,	1:10,	1:50,	1:100	dilutions	of	 the	sample	expecting	 to	have	higher	
levels	of	expression	of	the	desired	gene	were	used	to	assess	for	inhibition	of	the	qPCR	
and	 for	quantification.	Oligos	used	 for	qPCR	are	 indicated	 in	 Supplementary	Table	 S2.	
PCR	conditions	were:	an	initial	denaturation	step	at	95°C	for	2	min,	and	40	cycles	of	95°C	
10	seconds,	57.4°C	for	10	seconds	and	72°C	for	10	seconds.	Melting	curve	at	the	end	of	
the	run	and	agarose	electrophoresis	confirmed	single	and	specific	product	of	the	PCR.	
	
miRNA	cleavage	site	determination	by	5'RACE	
miRNA	cleavage	site	determination	was	performed	as	previously	described	66.	Briefly,	10	
µg	 of	 total	 RNA	 was	 ligated	 with	 an	 RNA	 oligo	 (5'-
CGACUGGAGCACGAGGACACUGACAUGGACUGAAGGAGUAGAAA-3')	 by	 using	 T4	 RNA	
ligase	 for	 1h	 at	 37°C.	 RNA	was	purified	with	phenol:chloroform	and	precipitated	with	
ethanol	and	sodium	acetate.	The	precipitated	RNA	was	retrotranscribed	into	cDNA	with	
SuperScript	 IV	 reverse	 transcriptase	 (ThermoScientific)	 and	 random	 hexamers	 by	
following	 manufacturers	 recommendations.	 Then,	 2	 µl	 of	 the	 generated	 cDNA	 were	
used	as	template	of	a	PCR	using	primer	456	and	a	gene	specific	primer	(Supplementary	
Table	S2).	Finally	2	µl	of	this	PCR	was	used	as	a	template	of	a	second	PCR	with	primer	
457	 and	 a	 nested	 gene-specific	 primer.	 The	 PCR	 product	 was	 resolved	 in	 a	 2%	 (w/v)	
agarose	gel	and	those	DNA	fragments	with	the	expected	electrophoretic	mobility	were	
isolated	 from	 the	 gel	 and	 cloned	 into	 pGEM-T	 easy	 (Promega)	 for	 further	 Sanger	
sequencing.		
	
Fluorescence	measurements	in	plate	reader	
Fluorescence	measurement	 from	 live	cells	was	made	 in	a	FLUOstar	Omega	microplate	
reader	(BMG	Labtech).	Data	was	analyzed	in	R	(Supplementary	Methods).	
	
Flow	cytometry	
Cultures	 were	 grown	 to	 1-2x106	 cell/ml	 cell	 density,	 and	 fluorescent	 signals	 were	
acquired	in	a	BD	FACScan		(Cytek	modified).	mVenus-	and	mCherry-derived	fluorescence	
signals	 were	 determined	 by	 using	 488	 nm	 and	 561	 nm	 lasers,	 respectively,	 and	 the	
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following	 fluorescence	 parameters:	 FL-1	 (530/30	 nm)	 for	mVenus	 and	 615/25	 nm	 for	
mCherry.	Chlorophyll	was	detected	with	the	488	nm	laser	and	FL-3	(695/40	nm).	Flow	
cytometry	data	was	analyzed	using	FlowJo	software	(FlowJo).	Flow	cytometry	data	were	
exported	from	FlowJo	using	the	option	“CSV-scale”,	and	processed	in	R	(Supplementary	
Methods).	
	
Fluorescence	microscopy	
Live	 cells	were	 imaged	using	a	DMI6000B	Leica	 inverted	microscope,	equipped	with	a	
63X	PLANAPO	oil	immersion	objective	(1.4	NA).	mVenus	and	mCherry	fluorescent	filters	
were	 490-510/515/520-550	 nm	 and	 540-552/560/567-643	 nm	 (Ex./DC/Em.),	
respectively.	 Samples	were	 prepared	 in	 TAP	media	 using	 8-well	 glass	 bottom	µ-slides	
(Ibidi),	covered	with	poly-L-lysine	(Sigma).	 Images	were	acquired	using	LAS	X	software,	
and	analyzed	using	ImageJ	software.		
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Figures	legends	
	
Figure	 1.	 Construction	 of	 a	 synthetic	 circuit	 to	 measure	 miRNA-dependent	 gene	
repression.		
A.	The	 synthetic	gene	circuit	 to	measure	miRNA	activity	was	 formed	by	 two	modules:	
module	 1,	 consisting	 of	 a	 fluorescent	 reporter	 whose	 expression	 is	 linked	 to	 the	
production	 of	 a	miRNA;	 and	module	 2,	 comprising	 an	mRNA	 of	 a	 second	 fluorescent	
reporter	which	carried	a	target	site	for	the	miRNA	produced	by	module	1.			
B.	DNA	constructs	tested	for	module	1:	a	microRNA	precursor	sequence	was	introduced	
into	three	different	sites	 inside	a	Chlamydomonas	codon-optimized	mVenus	gene.	The	
mVenus	coding	sequence,	driven	by	the	PSAD	promoter	and	 flanked	by	PSAD	UTRs	or	
PSAD	 5’UTR	 and	 RBSC2	 3’UTR,	 was	 split	 into	 two	 exons	 by	 the	 second	 intron	 of	 the	
RBCS2	gene.	The	mVenus	cassette	was	fused	to	a	paromomycin-resistant	cassette	and	
transformed	into	the	UVM11	strain.		
C.	 Boxplot	 showing	 mVenus	 fluorescence	 measured	 from	 individual	 transformants	
carrying	the	constructs	above.	“backgr.”	corresponds	to	autofluorescence	of	the	UVM11	
	 19	
strain	 and	 “neg.	 control”	 corresponds	 to	 autofluorescence	 of	 clones	 transformed	
exclusively	 with	 the	 paromomycin	 resistant	 cassette.	 On	 top,	 number	 of	 clones	
measured	for	each	construct.		
	D.	Correlation	between	mVenus	fluorescence	and	 intronic-encoded	miRNA	levels.	The	
miRNA	precursor	was	integrated	inside	the	intron,	at	site	2.	Clones	expressing	different	
levels	of	mVenus	 fluorescence	were	 selected	 from	panel	C,	 and	grown	 to	exponential	
phase	 (2-3	 x	 106	 cells/ml).	 Fluorescence	was	measured	 from	 the	 cultures	 (top	 panel),	
and	RNA	extracted	for	small	RNA	Northern	blot	(bottom	panels).	mVenus	fluorescence	
is	 shown	 as	 the	 average	 of	 three	 measurements	 from	 each	 culture	 and	 standard	
deviation.	U6	and	miR1162	were	used	as	loading	controls.		
E.	Quantification	of	 the	miRNA	 levels	 from	Northern	Blots	 shown	 in	panel	D.	 amiRNA	
levels	 were	 normalized	 using	 the	 endogenous	 miRNA	 miR1162.	 Average	 value	 and	
standard	deviation	of	triplicate	measurements	are	shown.	
F.	 Growth	 on	 TAP	 media	 containing	 5-FI	 of	 clones	 expressing	 high	 levels	 of	 mVenus	
fluorescence	with	or	without	the	intronic	miRNA	against	the	MAA7	gene.	
	
	
	
Figure	2.	Construction	of	the	miRNA-dependent	repression	reporter	(Module	2)	
A.	Sites	 in	the	mCherry	mRNA	molecule	tested	for	repression.	The	21-nt	miRNA	target	
site	 of	 the	 amiRNA	 against	MAA7	 gene	 was	 introduced	 into	 several	 positions	 of	 the	
PSAD-derived	5’	and	3’	UTRs	flanking	the	mCherry	reporter	gene.	
B.	Measurement	of	mCherry	fluorescence	in	either	presence	or	absence	of	the	amiRNA.	
One	clone	expressing	 the	mCherry	gene	 from	each	construct	 in	A	was	 re-transformed	
with	a	cassette	containing	the	mVenus	gene	either	with	or	without	the	intronic	amiRNA	
against	 the	 sequenced	 introduced	 in	 the	 mCherry	 molecule.	 Only	 mVenus	 positive	
clones	 are	 shown.	 On	 top,	 number	 of	 clones	 analyzed	 in	 each	 condition.	 Double	
asterisks	indicate	significant	differences	between	clones	expressing	the	intronic	miRNA	
and	clones	expressing	a	control	construct	without	miRNA,	for	each	site	tested	(p<0.05,	
Mann-Whitney	U	test).	
	
Figure	3.	Generation	and	characterization	of	synthetic	miRNAs	and	target	3’UTR	
A.	Diagram	of	constructs	used	in	the	assay.	The	UVM11	strain	was	first	transformed	with	
the	CDS	of	 the	mCherry	gene	 flanked	by	PSAD-derived	5’	and	3’	UTRs.	Different	21-nt	
sequences,	 with	 perfect	 complementarity	 to	 the	 synthetic	 miRNAs	 generated,	 were	
introduced	 in	 the	3'	UTR	 	 (site	C	of	Figure	2A).	A	clone	with	high	mCherry	 fluorescent	
signal	was	then	re-transformed	with	a	cassette	containing	the	mVenus	gene,	either	with	
or	without	the	corresponding	intronic	synthetic	microRNA.		
B.	 Boxplot	 of	 mCherry	 fluorescence	 measured	 from	 individual	 clones	 obtained	 as	
indicated	 in	A.	Only	mVenus	positive	 clones	 from	each	 transformation	are	 shown.	On	
top,	number	of	clones	analyzed	for	each	construct.	Double	asterisks	indicate	significant	
differences	 between	 clones	 expressing	 the	 intronic	 miRNA	 and	 clones	 expressing	 a	
control	construct	without	miRNA	(p<0.05,	Mann-Whitney	U	test).		
C.	Synthetic	miRNA	sequences	and	levels	of	repression	calculated	from	plots	in	B.	
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Figure	4.	Characterization	of	the	repressive	activity	of	miR1	
A.	 mCherry	 fluorescent	 signal	 of	 clones	 displaying	 increasing	 levels	 of	 mVenus	
fluorescence.	“0”	corresponds	to	autofluorescence	of	the	UVM11	strain.	mCherry-only	
expressing	 strain	 (no.	1)	 is	duplicated	 to	 facilitate	 comparison.	Average	value	of	 three	
measurements	from	same	culture	and	standard	deviation	are	shown.	
B.	mCherry	 fluorescence	 vs.	mVenus	 fluorescence	 plot	 from	 clones	 shown	 in	A.	 Black	
dots	 correspond	 to	 clones	where	 the	mVenus	gene	 carries	 the	 intronic	miRNA.	White	
dot,	 clones	 expressing	 mVenus	 without	 intronic	 miRNA.	 Average	 value	 from	 three	
measurements	of	same	culture;	error	bars	correspond	to	standard	deviation.		
C.	Northern	 blots	 showing	mVenus	mRNA,	mCherry	mRNA	 and	miR1	miRNA	 levels	 of	
clones	in	panel	A.	RACK1	mRNA	was	used	as	loading	control	of	mRNAs	Northern	blots,	
and	U6	 and	 the	 endogenous	miR1157	 as	 loading	 control	 of	 the	 small	 RNAs	Northern	
blots.		
D.	Detection	of	miR1-dependent	mCherry	mRNA	cleavage	products.	Clones	expressing	
high	levels	of	the	mVenus	gene,	carrying	the	intronic	miR1	precursor	or	lacking	it,	were	
subjected	 to	 modified	 5’RACE.	 Arrowhead	 indicates	 the	 RT-PCR	 product	 that	 was	
recovered	from	the	gel	and	sequenced.		
E.	 Sequencing	 results	 of	 the	 RT-PCR	 product	 obtained	 in	 panel	 D.	 Arrowhead	 and	
numbers	indicate	the	cleavage	position	and	frequency,	respectively,	of	the	5’	end	of	the	
truncated	mCherry	mRNA	(top),	aligned	to	miR1	(bottom).		
F.	Cells	expressing	mCherry	only	were	mixed	with	cells	expressing	mCherry	and	mVenus.	
mVenus	 carried	 the	 intronic	miR1	 precursor	 (top	 panel),	 or	 lacked	 of	 intronic	miRNA	
(bottom	panel).		
	
Figure	5.	Modulation	of	the	miRNA	repressive	activity		
A. Plot	 of	 mCherry	 vs.	 mVenus	 fluorescence	 of	 independent	 clones.	 A	 strain	
expressing	 the	 mCherry	 gene	 carrying	 the	 target	 site	 for	 miR1	 with	 perfect	
complementarity	(black	dots)	or	mismatches	(white	dots)	was	re-transformed	with	the	
mVenus	 cassette	 harboring	 the	 intronic	 miR1	 precursor.	 Fluorescence	 of	 the	 host	
mCherry-expressing	strain	was	normalized	to	1.	Average	value	and	standard	deviation	of	
three	measurements	from	same	culture	are	shown.		
B. Plot	 of	 mCherry	 mRNA	 levels	 against	 mVenus	 fluorescence.	 mCherry	 mRNA	
levels	from	clones	in	panel	A	were	determined	by	RT-qPCR.	Black	dots	represent	clones	
expressing	 the	 mCherry	 gene	 with	 perfectly	 complementary	 miR1	 recognition	 site.	
White	 dots	 represent	 clones	 expressing	 the	 mCherry	 gene	 with	 a	 modified	 (2-nt	
mismatch)	 recognition	 site	 for	 miR1.	 Average	 value	 and	 standard	 deviation	 of	 three	
technical	replicates.			
C. Northern	blot	 to	detect	miR1	 levels	 in	clones	expressing	high	 levels	of	mVenus	
with	 the	 intronic	miR1	 precursor,	 or	without	miRNA	 (control).	 "Perfect",	 the	mCherry	
gene	had	a	miR1	target	site	with	perfect	complementarity;	"mismatch",	target	site	had	a	
2nt-mismatch	opposite	to	positions	10	and	11	of	the	miRNA.	
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D. Detection	of	miR1-dependent	mCherry	mRNA	cleavage	products	from	clones	 in	
panel	 C.	 Arrowhead	 indicates	 the	 RT-PCR	 product	 from	 the	 5’RACE.	 An	 endogenous	
miRNA	target	sequence,	OMT2	mRNA,	was	amplified	as	control.		
E. Sequencing	 results	 of	 the	 RT-PCR	 product	 amplified	 in	 D.	 Arrows	 indicate	 the	
cleavage	position	and	numbers	indicate	the	frequency	of	these	truncations.		
	
	
Figure	6.	De-repression	of	miR1	target	by	a	miRNA	decoy.		
A.	 Constructs	 utilized	 as	miRNA	 decoys.	 Target	mimicry	 sites	 (marked	 in	 orange)	 had	
perfect	 complementarity	 with	 miR1	 except	 for	 a	 3-nt	 bulge	 between	 nucleotides	
opposite	 to	positions	10	and	11	of	 the	miRNA	 (see	Supplementary	Figure	4A).	One	or	
two	 target	mimicry	 sites	were	 incorporated	 into	 the	PSAD	 3'UTR	of	 the	mVenus	gene	
(miRNA	decoy	1X	and	2X).		
B.	 Genetic	 circuit	 to	 inactivate	 synthetic	 miRNA	 by	 RNA	 decoys.	 First,	 a	 strain	 was	
transformed	with	a	mCherry	cassette	where	mCherry	mRNA	carried	an	imperfect	target	
site	of	miR1.	One	clone	 from	this	 transformation	was	re-transformed	with	an	mVenus	
construct	 carrying	 intronic	miR1.	 A	 clone	where	mCherry	was	 repressed	by	miR1	was	
finally	re-transformed	with	an	mVenus	construct	carrying	1	or	2	target	mimicry	sites	in	
the	 3’UTR.	 The	 three	 consecutive	 transformations	 were	 done	 using	 three	 different	
antibiotic	selections:	hygromycin,	paromomycin	and	zeocin.		
C.	 Boxplot	 showing	mCherry	 fluorescent	 signals	 of	 independent	 clones	 obtained	 from	
transformation	with	 constructs	 in	A.	All	 strains	were	 compared	 simultaneously	by	 the	
Kruskal-Wallis	test	of	variance	analysis.	Double	asterisks	indicate	significant	differences	
with	 control	 strain	 expressing	 miRNA-repressed	 mCherry	 	 (p<0.05,	 pairwise	 Mann-
Whitney	U	tests).	
	
	
	
Figure	7.	Construction	of	self-regulatory	loops	using	intronic	miRNAs.		
A.	 Intronic	 miRNA	 self-loop	 (iMSL).	 Intron	 is	 represented	 in	 grey,	 and	 miRNA	 and	
miRNA*	 sequences	 are	 drawn	 in	 blue	 and	 turquoise,	 respectively.	 Splicing	 and	
processing	of	 the	miRNA	precursor	 results	 in	 a	mature	miRNA	 that	 targets	 the	mRNA	
that	derives	from	the	same	RNA	molecule	as	the	miRNA.		
B.	 DNA	 constructs	 to	 test	 iMSL	 in	 Chlamydomonas.	 The	mVenus	 gene,	 driven	 by	 the	
PSAD	promoter	 and	 flanked	 by	 the	 PSAD	UTRs,	was	 used	 to	 host	 the	 intronic	miRNA	
precursor.	 Construct	 1,	 no	 intronic	 miRNA,	 no	 target	 sequence;	 construct	 2,	 intronic	
miRNA	 and	 no	 target	 site;	 construct	 3,	 intronic	 miRNA	 and	 target	 site	 with	 high	
complementarity;	construct	4,	intronic	miRNA	and	target	site	with	internal	mismatches.		
C.	 Boxplot	 showing	mVenus	 fluorescence	 signal	 of	 independent	 clones	 obtained	 from	
the	 transformations	 with	 constructs	 shown	 in	 B.	 Only	 mVenus	 positive	 clones	 are	
shown.	 "backgr."	 refers	 to	 autofluorescence	of	 the	UVM11	 strain.	On	 top,	 number	 of	
clones	 analyzed	 for	 each	 construct.	 All	 mVenus	 expressing	 strains	 were	 compared	
simultaneously	 by	 the	 Kruskal-Wallis	 test	 of	 variance	 analysis.	 “n.s”.	 indicates	 no	
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significance	 difference;	 double	 asterisks	 indicate	 significant	 differences	 with	 control	
strains	1	and	2	(p<0.05,	pairwise	Mann-Whitney	U	tests).	
	
D.	Cell-to-cell	variability	within	clones	expressing	different	levels	of	the	mVenus.	Single-
cell	 mVenus	 fluorescence	 was	 determined	 using	 flow	 cytometry.	 >8	 clones	 stably	
expressing	different	 levels	of	each	construct	 indicated	next	 to	 the	plot	were	grown	to	
early	 exponential	 phase.	mVenus	 fluorescence	 from	25,000	 cells	 from	each	 individual	
clone	was	measured	by	flow	cytometry.	Dots	in	the	graph	correspond	to	each	individual	
clone,	showing	average	and	CV2	of	the	mVenus	fluorescence	from	25,000	cells.		
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